Literature DB >> 33918106

Peptide-Based Strategies for Targeted Tumor Treatment and Imaging.

Abiodun Ayo1, Pirjo Laakkonen1,2.   

Abstract

Cancer is one of the leading causes of death worldwide. The development of cancer-specific diagnostic agents and anticancer toxins would improve patient survival. The current and standard types of medical care for cancer patients, including surgery, radiotherapy, and chemotherapy, are not able to treat all cancers. A new treatment strategy utilizing tumor targeting peptides to selectively deliver drugs or applicable active agents to solid tumors is becoming a promising approach. In this review, we discuss the different tumor-homing peptides discovered through combinatorial library screening, as well as native active peptides. The different structure-function relationship data that have been used to improve the peptide's activity and conjugation strategies are highlighted.

Entities:  

Keywords:  drug delivery; targeted delivery; tumor homing peptides

Year:  2021        PMID: 33918106     DOI: 10.3390/pharmaceutics13040481

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  10 in total

1.  Hybridization of tumor homing and mitochondria-targeting peptide domains to design novel dual-imaging self-assembled peptide nanoparticles for theranostic applications.

Authors:  Syed Faheem Askari Rizvi; Samiah Shahid; Shuai Mu; Haixia Zhang
Journal:  Drug Deliv Transl Res       Date:  2021-09-17       Impact factor: 4.617

2.  A Small Peptide Increases Drug Delivery in Human Melanoma Cells.

Authors:  Shirley Tong; Shaban Darwish; Hanieh Hossein Nejad Ariani; Kate Alison Lozada; David Salehi; Maris A Cinelli; Richard B Silverman; Kamaljit Kaur; Sun Yang
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

Review 3.  EGFR-Targeted Photodynamic Therapy.

Authors:  Luca Ulfo; Paolo Emidio Costantini; Matteo Di Giosia; Alberto Danielli; Matteo Calvaresi
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

4.  Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands.

Authors:  Yi-An Chen; Cheau-Ling Ho; Min-Tzu Ku; Luen Hwu; Cheng-Hsiu Lu; Sain-Jhih Chiu; Wen-Yi Chang; Ren-Shyan Liu
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

Review 5.  Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints.

Authors:  Elza N Mathew; Bethany C Berry; Hong Wei Yang; Rona S Carroll; Mark D Johnson
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

6.  Structural Requirements for the Binding of a Peptide to Prohibitins on the Cell Surface of Monocytes/Macrophages.

Authors:  Qindong Zhang; Anniken Olberg; Mouldy Sioud
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

7.  Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer.

Authors:  Prakash Gangadaran; Gowri Rangaswamy Gunassekaran; Ramya Lakshmi Rajendran; Ji Min Oh; Sri Murugan Poongkavithai Vadevoo; Ho Won Lee; Chae Moon Hong; Byungheon Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Biomedicines       Date:  2022-08-15

Review 8.  Peptide therapeutics in the management of metastatic cancers.

Authors:  Debopriya Bose; Laboni Roy; Subhrangsu Chatterjee
Journal:  RSC Adv       Date:  2022-08-02       Impact factor: 4.036

Review 9.  Matrices and Affinity Ligands for Antibody Purification and Corresponding Applications in Radiotherapy.

Authors:  Aiying Xue; Saijun Fan
Journal:  Biomolecules       Date:  2022-06-12

10.  Multifunctional self-assembled peptide nanoparticles for multimodal imaging-guided enhanced theranostic applications against glioblastoma multiforme.

Authors:  Syed Faheem Askari Rizvi; Azam Ali; Munir Ahmad; Shuai Mu; Haixia Zhang
Journal:  Nanoscale Adv       Date:  2021-09-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.